Literature DB >> 8332103

Characterization of the cellular response of spleen cells in BALB/c mice inoculated with Mycoplasma pneumoniae or the P1 protein.

K Pietsch1, E Jacobs.   

Abstract

BALB/c mice were intranasally infected or intraperitoneally inoculated with Mycoplasma pneumoniae whole cells or were immunized with the isolated adhesin (P1 protein). Spleen cells were isolated and tested in vitro for proliferation activity after stimulation with the P1 protein and sonicated M. pneumoniae whole antigen preparations. In frequency analysis experiments the P1 protein-specific proliferative response of spleen lymphocytes increased from 1/11494 in mice immunized once to 1/3246 in eightfold-inoculated mice, demonstrating that the P1 protein is a prominent immunogen of M. pneumoniae cells. Depletion experiments showed that T and B cells are activated in a 2:1 relation. Fluorescence-activated cells sorting analysis revealed a shift of the CD4/CD8 ratio from 2:1 in control mice up to 3:1 in M. pneumoniae-, and to 3.4:1 in P1 protein-immunized mice, as well as an increase in interleukin 2 receptor-bearing cells and macrophage cell populations. The results indicate that this animal model is appropriate to study host-M. pneumoniae interactions and vaccination schedules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332103     DOI: 10.1007/bf00189375

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  18 in total

Review 1.  Mycoplasma adhesion.

Authors:  S Razin; E Jacobs
Journal:  J Gen Microbiol       Date:  1992-03

2.  A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae.

Authors:  E Jacobs; R Röck; L Dalehite
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 3.  Antigen-presenting function of the macrophage.

Authors:  E R Unanue
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 4.  Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control.

Authors:  F W Denny; W A Clyde; W P Glezen
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

5.  Computer aided design and evaluation of limiting and serial dilution experiments.

Authors:  L W Strijbosch; R J Does; W A Buurman
Journal:  Int J Biomed Comput       Date:  1988-12

6.  Release of Mycoplasma pneumoniae substances after phagocytosis by guinea pig alveolar macrophages.

Authors:  M Kist; E Jacobs; W Bredt
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 7.  Immunization against Mycoplasma pneumoniae disease: a review.

Authors:  M F Barile
Journal:  Isr J Med Sci       Date:  1984-10

8.  T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation.

Authors:  R H Schwartz; L Jackson; W E Paul
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.

Authors:  M F Barile; D K Chandler; H Yoshida; M W Grabowski; S Razin
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease.

Authors:  K Lind; M Høier-Madsen; A Wiik
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

View more
  2 in total

1.  Animal model of Mycoplasma pneumoniae infection using germfree mice.

Authors:  Masayuki Hayakawa; Haruhiko Taguchi; Shigeru Kamiya; Yasunori Fujioka; Hidehiro Watanabe; Shin Kawai; Hiroyuki Kobayashi
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl.

Authors:  Florian Daxboeck; Bernhard Eisl; Christofer Burghuber; Mazda Memarsadeghi; Ojan Assadian; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.